Live Quote · NASDAQABUSHealthcare· Biotechnology

Arbutus Biopharma Corp

$4.02▼ 1.23%($-0.05)
MKT CAP $616.24MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
79/100
▌ Solid
73
Valuation
100
Profitability
100
Growth
92
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABUS research report →

Analyst Price Target
$8.50+111.4% vs. today

Range $8.5 – $8.5

Analyst RatingBuy
8 Buy2 Hold0 Sell

Price Chart

-4.29% · this period
$5.22$4.44$3.66Nov 20May 26Nov 20
52-Week Range27% of range
Low
$3.50
Current
$4.02
High
$5.45